Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8K Hold
183
﹤0.01% 1116
2026
Q1
$17.6K Hold
183
﹤0.01% 1179
2025
Q4
$18.6K Hold
183
﹤0.01% 959
2025
Q3
$15.9K Buy
183
+86
+89% +$6.8K ﹤0.01% 978
2025
Q2
$6.61K Hold
97
﹤0.01% 532
2025
Q1
$5.87K Hold
97
﹤0.01% 502
2024
Q4
$6.7K Sell
97
-3
-3% -$214 ﹤0.01% 485
2024
Q3
$6.61K Hold
100
﹤0.01% 503
2024
Q2
$6.06K Hold
100
﹤0.01% 509
2024
Q1
$5.7K Hold
100
﹤0.01% 619
2023
Q4
$5.78K Hold
100
﹤0.01% 565
2023
Q3
$5.78K Buy
+100
New +$6.3K ﹤0.01% 563
2020
Q2
Sell
-100
Closed -$7K 137
2020
Q1
$7K Hold
100
﹤0.01% 182
2019
Q4
$9K Hold
100
﹤0.01% 187
2019
Q3
$7K Hold
100
﹤0.01% 180
2019
Q2
$8K Hold
100
﹤0.01% 173
2019
Q1
$9K Hold
100
﹤0.01% 167
2018
Q4
$6K Buy
+100
New +$6.49K ﹤0.01% 169

Other funds holding INCY

Salomon & Ludwin's INCY Position: Q2 2026 in Review

Salomon & Ludwin held its Incyte (INCY) position steady in Q2 2026 at 183 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

Salomon & Ludwin first reported a position in INCY in Q4 2018 and has held it in 18 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Salomon & Ludwin held 183 shares of Incyte worth $20.8K as of Q2 2026.
  • Salomon & Ludwin left its Incyte share count unchanged in Q2 2026.
  • Incyte made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1116 holding.
  • Salomon & Ludwin first reported a position in Incyte in Q4 2018 and has held it in 18 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.